Two Seas investeert sinds 2022 in Core Scientific, nam deel aan de claimemissie begin 2024 en participeerde in beide converteerbare obligatie-uitgiftes. De firma zei momenteel het economisch eigendom ...

Two Seas Capital moves to block CoreWeave’s $9B all-stock deal for Core Scientific, citing low valuation and high risk.

Two Seas Capital LP, the largest active shareholder of Core Scientific, Inc., announced Thursday its opposition to the ...

Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and the largest active shareholder of ...

Two Seas Capital has come out against Core Scientific's proposed all-stock acquisition by AI cloud provider CoreWeave.

Two Seas Capital opposes Core Scientific's all-stock acquisition by CoreWeave, citing undervaluation and risk.

Two Seas Capital opposes CoreWeave’s acquisition of Core Scientific, citing shareholder risk and sparking debate on AI ...

Core Scientific's largest shareholder, Two Seas Capital LP, has announced its opposition to the $9bn acquisition proposed by ...

CoreWeave’s acquisition of Core Scientific is facing shareholder pushback, sparking a rally in AI tokens and centralization questions.